Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Oracle’s Strategic Gambit: A High-Stakes Clash Between TikTok Deal and Bearish Bets

Andreas Sommer by Andreas Sommer
January 23, 2026
in Analysis, Mergers & Acquisitions, Nasdaq, Tech & Software
0
Oracle Stock
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

Oracle Corporation finds itself at the center of a compelling market narrative, caught between a significant strategic victory and mounting skepticism from prominent investors. The software giant’s recent move to secure a stake in TikTok’s U.S. operations through a new joint venture is being directly challenged by bearish wagers, most notably from famed investor Michael Burry.

The TikTok Agreement: A Data and Cloud Coup

After protracted negotiations, a resolution for TikTok’s U.S. operations has been reached, placing Oracle in a pivotal position. Under the terms of the deal, a consortium of U.S. and global investors will hold an 80.1% stake in the video app’s American division. Oracle, alongside Silver Lake and Abu Dhabi-based MGX, is set to acquire a 15% share each, while ByteDance retains a minority holding of 19.9%.

The arrangement, confirmed by former President Donald Trump who praised the new owners, grants Oracle more than prestige. It provides the company with operational oversight of the data and algorithms underpinning a massive user base—a strategic asset that aligns seamlessly with Oracle’s expanding cloud infrastructure ambitions.

Mounting Concerns Amid Growth

Despite this positive development, Oracle’s share price has faced considerable pressure, declining approximately 16% over the past 30 trading days. This market unease is embodied by Michael Burry of “The Big Short” fame, who has taken a public bearish stance. Burry has purchased put options, positioning for a further decline in the stock, and cites several fundamental concerns:

Should investors sell immediately? Or is it worth buying Oracle?

  • Substantial Liabilities: Burry points to Oracle’s debt and lease obligations, which total around $124 billion.
  • Cash Flow Pressure: The company reported a negative free cash flow of $10 billion for its second fiscal quarter.
  • Aggressive Capex: Planned expenditures approaching $50 billion for the 2026 fiscal year pose a risk in an uncertain macroeconomic climate.

Burry’s central critique questions how Oracle intends to finance such aggressive expansion should demand for its services soften.

Impressive Metrics Versus Valuation Volatility

Countering these warnings are robust growth figures from Oracle’s core cloud business. The company recently reported cloud revenue surged 34% to $8.0 billion. A key indicator, the remaining performance obligation (RPO), skyrocketed to $523 billion, fueled in large part by long-term commitments from technology leaders like Meta and Nvidia.

The current investor sentiment appears divided. While retail investor activity suggests optimism regarding the TikTok involvement, equity analysts are adopting a more measured view, carefully weighing the evident growth potential against the balance sheet risks highlighted by critics. The coming quarters will be critical in determining whether Oracle’s operational cloud momentum can generate sufficient returns to offset its capital costs and reverse the recent downward trend in its share price.

Ad

Oracle Stock: Buy or Sell?! New Oracle Analysis from February 7 delivers the answer:

The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Oracle: Buy or sell? Read more here...

Tags: Oracle
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

February 7, 2026
Guaranty Bancshares Stock
Analysis

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock
AI & Quantum Computing

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
Next Post
Salesforce Stock

Salesforce at a Crossroads: AI Ambition Meets Market Anxiety

Cardano Stock

Cardano Approaches a Technical and Fundamental Inflection Point

Take-Two Stock

Take-Two Shares Navigate a Holding Pattern Ahead of Grand Theft Auto VI Launch

Recommended

C3.ai Stock

Is C3.ai Stock Poised for a Rebound?

2 months ago
MMM stock news

Clarification on Hyperlink and Promotional Fees

2 years ago

XOMA Corporation Expands Portfolio with Acquisition of DSUVIA

2 years ago
Microsoft Stock

A Bold Bet: Peter Thiel’s Hedge Fund Doubles Down on Microsoft

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Trending

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

by SiterGedge
February 7, 2026
0

Avanos Medical is navigating a critical strategic transformation. The medical device firm is streamlining its operations to...

Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth
  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com